Company · CIK 1121404
Sanofi
| CIK | 1121404 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | I0 |
| Business address | France |
| Listed | SNY (Nasdaq), SNYNF (OTC) |
| First annual or quarterly report | 2003-06-23 |
Offerings
0 registrationsNo offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-10-29 | 424B5Shelf takedown | 333-278506 | 0001193125-25-255563 |
| 2025-10-27 | 424B5Shelf takedown | 333-278506 | 0001193125-25-250786 |
| 2018-06-14 | 424B5Shelf takedown | 333-210203 | 0001193125-18-192851 |
| 2018-06-12 | 424B5Shelf takedown | 333-210203 | 0001193125-18-190058 |
| 2013-04-05 | 424B5Shelf takedown | 333-187156 | 0001047469-13-004002 |
| 2013-04-03 | 424B5Shelf takedown | 333-187156 | 0001047469-13-003866 |
| 2011-09-28 | 424B5Shelf takedown | 333-165472 | 0001193125-11-258723 |
| 2011-09-27 | 424B5Shelf takedown | 333-165472 | 0001193125-11-256884 |
| 2011-03-29 | EFFECTDeclared effective | 333-172638 | 9999999995-11-000816 |
| 2011-03-24 | 424B5Shelf takedown | 333-165472 | 0001193125-11-076365 |
| 2011-03-22 | 424B5Shelf takedown | 333-165472 | 0001193125-11-073178 |
| 2007-10-12 | EFFECTDeclared effective | 333-145177 | 9999999995-07-004039 |
| 2004-11-10 | 424B5Shelf takedown | 333-112314 | 0000950123-04-013372 |
| 2004-05-28 | 424B5Shelf takedown | 333-112314 | 0000950123-04-006922 |
| 2004-04-12 | 424B5Shelf takedown | 333-112314 | 0000950123-04-004490 |